Host immune and microbiota ecosystem

The host immune and microbiota ecosystem refers to the complex, bidirectional symbiotic relationship between a host's immune system and the diverse microbial communities inhabiting mucosal surfaces, particularly the gastrointestinal tract. This ecosystem is fundamental to human health, as the microbiota provides essential signals for the development and regulation of innate and adaptive immune responses, while the immune system maintains the balance between commensal tolerance and pathogen defense (Belkaid & Hand, 2014). Disruptions in this delicate equilibrium, known as dysbiosis, are linked to a wide range of pathologies, including inflammatory bowel disease (IBD), metabolic syndrome, autoimmune disorders, and altered responses to cancer immunotherapies (Lynch & Pedersen, 2016). While not a single molecular target, the ecosystem is increasingly viewed as a therapeutic landscape. Interventions such as fecal microbiota transplantation (FMT), probiotics, and prebiotics aim to restore microbial diversity and functional homeostasis to treat conditions like recurrent Clostridioides difficile infection. Furthermore, the composition of the gut microbiome has been shown to significantly influence the efficacy and safety of systemic drugs, including immune checkpoint inhibitors, by modulating the host's systemic inflammatory state (Gopalakrishnan et al., 2018). Understanding this ecosystem is critical for the development of precision medicine approaches that leverage microbial modulation to enhance therapeutic outcomes.

Restoration of microbial diversity, competitive exclusion of pathogenic species, production of immunomodulatory metabolites such as short-chain fatty acids (SCFAs), and modulation of Toll-like receptor (TLR) signaling to restore immune homeostasis.